ODAG Reporting Requirements for Medicare Advantage Plans

ODAG reporting requirements obligate every Medicare Advantage Organization to compile and submit annual data to CMS on three categories of plan activity: organization determinations, appeals (reconsiderations), and grievances. Submissions go through the Health Plan Management System, cover case-level detail across five subsections, and are due in late February each year for the preceding calendar year. The underlying rules sit in 42 CFR Part 422, Subpart M, and CMS tests the accuracy of what plans submit through annual data validation and periodic program audits.

A parallel framework called CDAG governs the same processes for Part D prescription drug plans.1CMS. Parts C and D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance ODAG is specific to Part C medical services; if your question is about drug coverage decisions, you want CDAG.

What the Three Categories Cover

Each piece of the acronym is governed by 42 CFR Part 422, Subpart M.2eCFR. 42 CFR Part 422, Subpart M — Grievances, Organization Determinations and Appeals

  • An organization determination is any decision a plan makes about whether to cover a service, item, or Part B drug, and about enrollee cost sharing. It can be standard or expedited, and can arise before or after a service is delivered.
  • A reconsideration is the Level 1 appeal a plan conducts when an enrollee or provider disagrees with an adverse organization determination. Adverse reconsiderations proceed to an Independent Review Entity, and from there can escalate to an Administrative Law Judge, the Medicare Appeals Council, and federal court.1CMS. Parts C and D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance
  • A grievance is an expression of dissatisfaction with the plan’s operations, activities, or behavior that is not a coverage dispute. Complaints about rude staff, appointment access, and quality of care all fall here.3CMS. Grievances

What Plans Submit

ODAG data is organized into five subsections: organization determinations, their dispositions, reconsiderations, reconsideration dispositions, and reopened cases.4CMS. CY 2025 Part C Technical Specifications

Volume and Disposition

For both organization determinations and reconsiderations, plans report the total number of decisions made during each quarter, plus withdrawals and dismissals. Volume figures are broken down by requestor type (enrollee, representative, contracted provider, or non-contracted provider) and by whether the request involved a service or a claim. Each decision is classified as fully favorable, partially favorable, or adverse. Withdrawals and dismissals sit outside the total count.4CMS. CY 2025 Part C Technical Specifications

Reopened Cases

When a plan revisits a prior decision, it uploads case-level data for each reopening: contract number, case ID, original disposition, date of the original decision, reason for reopening (clerical error, fraud, new evidence, and so on), and revised disposition.5CMS. CY 2025 Part C Reporting Requirements A reopened case belongs in the quarter in which the enrollee was notified of the revised decision, not the quarter the reopening was initiated.6CMS. CY 2026 Part C Technical Specifications

Grievances

Plans report total grievances, expedited grievances, timely notifications, and dismissed grievances. A quality-of-care grievance is a complaint about whether covered services met professionally recognized standards, including whether care was appropriate and whether it was delivered in the right setting.5CMS. CY 2025 Part C Reporting Requirements

Deadlines and Retention

Data is collected quarterly but compiled into a single annual submission through HPMS. Grievance data is due by the first Monday of February following the reporting year. Organization determinations and reconsiderations data is due by the last Monday of February.7CMS. CY 2026 Part C Reporting Requirements All submissions must be in by 11:59 p.m. Pacific Time on the deadline date.

If a plan discovers errors after the deadline, it can request CMS permission to resubmit, but corrections must be in by March 31. Once CMS approves a resubmission request, the plan has seven days or until March 31, whichever comes first.6CMS. CY 2026 Part C Technical Specifications

Plans must retain a complete archive of every HPMS submission and resubmission for ten years and produce them to CMS on request.7CMS. CY 2026 Part C Reporting Requirements

Processing Timeframes Behind the Numbers

The ODAG data effectively measures whether plans met the adjudication timeframes set by regulation.

For expedited organization determinations involving a service or item, the plan has 72 hours from receipt to notify the enrollee. For expedited Part B drug requests, the window is 24 hours, with no extensions permitted. The 72-hour service window can be extended by up to 14 calendar days at the enrollee’s request, when additional information from a non-contracted provider is needed, or under other extraordinary circumstances.8Legal Information Institute. 42 CFR § 422.572

For standard organization determinations, the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) shortened the decision timeline from 14 to seven calendar days, effective January 1, 2026.9CMS. CMS Interoperability and Prior Authorization Final Rule Fact Sheet

Grievances must be resolved within 30 days of receipt, extendable by up to 14 days when the extension is in the enrollee’s best interest. Certain expedited grievances, such as a complaint about a plan’s refusal to grant an expedited organization determination, require a response within 24 hours.3CMS. Grievances

Missing any of these timeframes constitutes an adverse organization determination that the enrollee can then appeal.8Legal Information Institute. 42 CFR § 422.572

How CMS Tests the Data

CMS does not accept ODAG submissions at face value. An independent Data Validation Contractor evaluates each plan’s data between April 1 and June 15, reviewing source code, data queries, and spreadsheet formulas; pulling sample files and comparing them to reported figures; interviewing staff; and observing reporting processes. CMS then issues a pass or not-pass determination, and plans can appeal a not-pass within five business days of the validation deadline.10RegInfo.gov. CMS Data Validation Manual

Separately, CMS conducts program audits using the protocols in the CMS-10717 audit package.11CMS. Program Audits The ODAG audit universe pulls in multiple tables: organization determination records, reconsideration records, payment cases, grievance records, and reopened cases. Each record requires fields including the date the request was received, the disposition, whether processing was expedited, the requestor type, and whether the provider was contracted.12Regulations.gov. 2027 Draft CMS-10717 Audit Protocols

Audits run in four phases. CMS sends an engagement letter and requests universe files; inaccurate or incomplete data at this stage can produce an “Invalid Data Submission” finding on its own. Field work typically runs two weeks via webinar or desk review. If auditors find noncompliance, the plan must produce a root cause analysis within two business days and an impact analysis within ten business days. Findings are classified as observations, corrective actions required, or invalid data submissions. A plan cited for corrective action submits a corrective action plan within 30 calendar days and has 180 days from acceptance to complete validation; if more than five conditions require validation, the plan must hire an independent auditor.13CMS. Program Audit Process Overview

CMS’s 2024 Audit and Enforcement Report flagged recurring deficiencies: coverage requests misclassified or inappropriately dismissed (sometimes because electronic prior authorization systems routed appeals as new initial requests), clinical reviewers overlooking pertinent information in medical histories before adverse decisions, and system errors producing delayed or incomplete notifications. Compliance programs also frequently failed to catch delegated entities misinterpreting regulations.14CMS. 2024 CMS Program Audit and Enforcement Report

Enforcement Consequences

Under 42 CFR Part 422, Subpart O, CMS can impose civil money penalties, intermediate sanctions (suspensions of marketing, enrollment, or payment), or terminate a plan’s contract.15CMS. Part C and Part D Enforcement Actions In 2024, CMS imposed civil money penalties on 14 plan sponsors across 18 violations, with 16 of those violations carrying aggravating factors tied to acute medical conditions, denial of services, or prior offenses.16Healthcare Dive. CMS Audit Report Fines Rising

Recent Rulemaking Reshaping What Plans Track

Several 2024 and 2025 rulemaking actions have added or shifted ODAG-adjacent obligations.

Shorter Timelines and Denial Transparency

CMS-0057-F, released in January 2024, compressed the standard organization determination timeline from 14 to seven calendar days and required plans to provide a specific reason for every denied prior authorization, no matter the delivery channel. Operational provisions had to be in place by January 1, 2026; API-related provisions are due by January 1, 2027. Plans must also publicly report annual prior authorization metrics, with the first set due March 31, 2026.9CMS. CMS Interoperability and Prior Authorization Final Rule Fact Sheet17CMS. CMS Interoperability and Prior Authorization Final Rule

Health Equity Analysis of Prior Authorization

The Contract Year 2025 Final Rule (CMS-4205-F) requires each plan’s utilization management committee to include at least one member with health equity expertise and to conduct an annual, plan-level health equity analysis of prior authorization policies. Results must be published on the plan’s website, with the first analysis due by July 1, 2025.18CMS. Contract Year 2025 Medicare Advantage and Part D Final Rule Fact Sheet

Utilization Management Annual Data Submission

Starting in 2026, CMS finalized a new annual data submission (CMS-10913) requiring all MA plans to report the internal coverage criteria they use to process prior authorizations for Part C services, including Part B drugs. The initial submission for the 2026 coverage year was due April 30, 2026, with subsequent annual submissions due each February 28. The data covers criteria developed by the plan, its delegated entities, and third-party clinical vendors; concurrent and payment reviews are excluded.19CMS. Part C Utilization Management Annual Data Submission20CMS. 2026 UM Annual Data Submission Instructions

Appeals Revisions in CY 2025

The CY 2025 Final Rule shifted responsibility for reviewing untimely fast-track appeals of service terminations in skilled nursing facilities, rehabilitation facilities, and home health settings from the MA plan to the Quality Improvement Organization. It also eliminated the rule that forced enrollees to forfeit their right to appeal a service termination if they left the facility before the appeal deadline.18CMS. Contract Year 2025 Medicare Advantage and Part D Final Rule Fact Sheet

Regulatory Foundation

The reporting obligation itself sits in 42 CFR § 422.516(a), which requires MA Organizations to develop, compile, evaluate, and report information to CMS in the manner and at the times CMS requires.5CMS. CY 2025 Part C Reporting Requirements The substantive rules on how plans must handle organization determinations, appeals, and grievances live in 42 CFR Part 422, Subpart M (§§ 422.560–422.634), with authority flowing from Sections 1852(f) and 1852(g) of the Social Security Act.21eCFR. 42 CFR Part 422, Subpart M CMS’s operational guidance is the “Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance,” most recently updated with an effective date of November 18, 2024.22CMS. Updated Addendum to the Parts C and D Grievances, Determinations, and Appeals Guidance